The use of cardiac troponins and B-type natriuretic peptide in COVID-19

References

• Anon: COVID-19 Map. Johns Hopkins Coronavirus Resource Center. [cited 2021 Feb 21]. Available from: https://coronavirus.jhu.edu/map.html
   Google Scholar
• Shi S, Qin M, Shen B, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020;5(7):802–810.
   PubMed Web of Science ®Google Scholar
• Sharma S, Jackson PG, Makan J. Cardiac troponins. J Clin Pathol. 2004;57(10):1025–1026.
   PubMed Web of Science ®Google Scholar
• Rao SV, Ohman EM, Granger CB, et al. Prognostic value of isolated troponin elevation across the spectrum of chest pain syndromes. Am J Cardiol. 2003;91(8):936–940.
   Web of Science ®Google Scholar
• Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018). J Am Coll Cardiol. 2018;72(18):2231–2264.
   PubMed Web of Science ®Google Scholar
• Landesberg G, Jaffe AS, Gilon D, et al. Troponin elevation in severe sepsis and septic shock: the role of left ventricular diastolic dysfunction and right ventricular dilatation*. Crit Care Med. 2014;42(4):790–800.
   PubMed Web of Science ®Google Scholar
• Thachil J, Tang N, Gando S, et al. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost. 2020;18(5):1023–1026.
   PubMed Web of Science ®Google Scholar
• Siripanthong B, Nazarian S, Muser D, et al. Recognizing COVID-19-related myocarditis: the possible pathophysiology and proposed guideline for diagnosis and management. Heart Rhythm. 2020;17(9):1463–1471.
   PubMed Web of Science ®Google Scholar
• Sala S, Peretto G, Gramegna M, et al. Acute myocarditis presenting as a reverse Tako-Tsubo syndrome in a patient with SARS-CoV-2 respiratory infection. Eur Heart J. 2020;41(19):1861–1862.
   PubMed Web of Science ®Google Scholar
• The European Society for Cardiology: ESC Guidance for the Diagnosis and Management of CV Disease during the COVID-19 Pandemic. [cited 2021 Feb 21]. Available from: https://www.escardio.org/Education/COVID-19-and-Cardiology/ESCCOVID-19-Guidance
   Google Scholar
• Kang Y, Chen T, Mui D, et al. Cardiovascular manifestations and treatment considerations in COVID-19. Heart. 2020;106(15):1132–1141.
   PubMed Web of Science ®Google Scholar
• Koutsoukis A, Delmas C, Roubille F, et al. Acute coronary syndromes in the era of SARS-CoV-2 infection: a registry of the French group of acute cardiac care. CJC Open. 2020;3(3):311–317.
   Google Scholar
• Musher DM, Abers MS, Corrales-Medina VF. Acute infection and myocardial infarction. N Engl J Med. 2019;380(2):171–176.
   PubMed Web of Science ®Google Scholar
• Bansal A, Kumar A, Patel D, et al. Meta-analysis comparing outcomes in patients with and without cardiac injury and coronavirus disease 2019 (COVID 19). Am J Cardiol. 2021;141:140–146.
   Web of Science ®Google Scholar
• Vrints CJM, Krychtiuk KA, Van Craenenbroeck EM, et al. Endothelialitis plays a central role in the pathophysiology of severe COVID-19 and its cardiovascular complications. Acta Cardiol. 2020;76(2):109–124..
   Web of Science ®Google Scholar
• Lowenstein CJ, Solomon SD. Severe COVID-19 is a microvascular disease. Circulation. 2020;142(17):1609–1611.
   PubMed Web of Science ®Google Scholar
• Arlati S, Brenna S, Prencipe L, et al. Myocardial necrosis in ICU patients with acute non-cardiac disease: a prospective study. Intensive Care Med. 2000;26(1):31–37.
   Web of Science ®Google Scholar
• Chen T, Wu D, Chen H, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020;368:m1091.
   PubMed Web of Science ®Google Scholar
• Guo T, Fan Y, Chen M, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5(7):811–818.
   PubMed Web of Science ®Google Scholar
• Metzler B, Siostrzonek P, Binder RK, et al. Decline of acute coronary syndrome admissions in Austria since the outbreak of COVID-19: the pandemic response causes cardiac collateral damage. Eur Heart J. 2020;41(19):1852–1853.
   PubMed Web of Science ®Google Scholar
• De Rosa S, Spaccarotella C, Basso C, et al. Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era. Eur Heart J. 2020;41(22):2083–2088.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Leor O, Cid-Alvarez B, Ojeda S. Impact of the COVID‐19 pandemic on interventional cardiology activity in Spain. REC Interv Cardiol. 2020;2:82–89.
   Google Scholar
• Solomon MD, McNulty EJ, Rana JS, et al. The covid-19 pandemic and the incidence of acute myocardial infarction. N Engl J Med. 2020;383(7):691–693.
   PubMed Web of Science ®Google Scholar
• Mafham MM, Spata E, Goldacre R, et al. COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England. Lancet. 2020;396(10248):381–389.
   PubMed Web of Science ®Google Scholar
• Rangé G, Hakim R, Beygui F, et al. Incidence, delays, and outcomes of STEMI during COVID-19 outbreak: analysis from the France PCI registry. J Am Coll Emerg Physicians Open. 2020;1(6):1168–1176.
   Google Scholar
• Vasile VC, Chai H-S, Khambatta S, et al. Significance of elevated cardiac troponin T levels in critically ill patients with acute respiratory disease. Am J Med. 2010;123(11):1049–1058.
   Web of Science ®Google Scholar
• Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062.
   PubMed Web of Science ®Google Scholar
• Al Abbasi B, Torres P, Ramos-Tuarez F, et al. Cardiac troponin-I and COVID-19: a prognostic tool for in-hospital mortality. Cardiol Res. 2020;11(6):398–404.
   Web of Science ®Google Scholar
• Karbalai Saleh S, Oraii A, Soleimani A, et al. The association between cardiac injury and outcomes in hospitalized patients with COVID-19. Intern Emerg Med. 2020;15(8):1415–1424.
   Web of Science ®Google Scholar
• Kinnunen P, Vuolteenaho O, Ruskoaho H. Mechanisms of atrial and brain natriuretic peptide release from rat ventricular myocardium: effect of stretching. Endocrinology. 1993;132(5):1961–1970.
   PubMed Web of Science ®Google Scholar
• Ponikowski P, Voors AA, Anker SD, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European society of cardiology (ESC). Eur J Heart Fail. 2016;18(8):891–975.
   PubMed Web of Science ®Google Scholar
• Ibrahim NE, Burnett JCJ, Butler J, et al. Natriuretic peptides as inclusion criteria in clinical trials: a JACC: heart failure position paper. JACC Heart Fail. 2020;8(5):347–358.
   PubMed Web of Science ®Google Scholar
• Pranata R, Huang I, Lukito AA, et al. Elevated N-terminal pro-brain natriuretic peptide is associated with increased mortality in patients with COVID-19: systematic review and meta-analysis. Postgrad Med J. 2020;96(1137):387–391.
   PubMed Web of Science ®Google Scholar
• Sorrentino S, Cacia M, Leo I, et al. B-Type natriuretic peptide as biomarker of COVID-19 disease severity-A meta-analysis. J Clin Med. 2020;9(9):2957.
   Web of Science ®Google Scholar
• Mitaka C, Hirata Y, Nagura T, et al. Increased plasma concentrations of brain natriuretic peptide in patients with acute lung injury. J Crit Care. 1997;12(2):66–71.
   Web of Science ®Google Scholar
• Gabarre P, Dumas G, Dupont T, et al. Acute kidney injury in critically ill patients with COVID-19. Intensive Care Med. 2020;46(7):1339–1348.
   PubMed Web of Science ®Google Scholar
• Panhwar MS, Kalra A, Gupta T, et al. Effect of influenza on outcomes in patients with heart failure. JACC Heart Fail. 2019;7(2):112–117.
   PubMed Web of Science ®Google Scholar
• Lai C-C, Sung M-I, Ho C-H, et al. The prognostic value of N-terminal proB-type natriuretic peptide in patients with acute respiratory distress syndrome. Sci Rep. 2017;7:44784.
   Web of Science ®Google Scholar
• Weber M, Hamm C. Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine. Heart. 2006;92(6):843–849.
   PubMed Web of Science ®Google Scholar
• Christ-Crain M, Breidthardt T, Stolz D, et al. Use of B-type natriuretic peptide in the risk stratification of community-acquired pneumonia. J Intern Med. 2008;264(2):166–176.
   PubMed Web of Science ®Google Scholar
• Mueller C, Laule-Kilian K, Frana B, et al. Use of B-type natriuretic peptide in the management of acute dyspnea in patients with pulmonary disease. Am Heart J. 2006;151(2):471–477.
   Web of Science ®Google Scholar
• Mueller C, McDonald K, de Boer RA, et al. Heart failure association of the European society of cardiology practical guidance on the use of natriuretic peptide concentrations. Eur J Heart Fail. 2019;21(6):715–731.
   PubMed Web of Science ®Google Scholar
• Gao L, Jiang D, Wen X-S, et al. Prognostic value of NT-proBNP in patients with severe COVID-19. Respir Res. 2020;21(1):83.
   PubMed Web of Science ®Google Scholar
• Sandoval Y, Januzzi JL, Jaffe AS. Jaffe as: cardiac troponin for assessment of myocardial injury in COVID-19: JACC review topic of the week. J Am Coll Cardiol. 2020;76(10):1244–1258.
   PubMed Web of Science ®Google Scholar
• Manocha KK, Kirzner J, Ying X. Troponin and other biomarker levels and outcomes among patients hospitalized with COVID-19: derivation and validation of the HA(2)T(2) COVID-19 mortality risk score. J Am Heart Assoc. 2020;10(6):e018477.
   Web of Science ®Google Scholar
• Santoso A, Pranata R, Wibowo A, et al. Cardiac injury is associated with mortality and critically ill pneumonia in COVID-19: a meta-analysis. Am J Emerg Med. 2020;44:352–357.
   Web of Science ®Google Scholar
• Li X, Guan B, Su T, et al. Impact of cardiovascular disease and cardiac injury on in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis. Heart. 2020;106(15):1142–1147.
   PubMed Web of Science ®Google Scholar
• Shao M-J, Shang L-X, Luo J-Y, et al. Myocardial injury is associated with higher mortality in patients with coronavirus disease 2019: a meta-analysis. J Geriatr Cardiol. 2020;17(4):224–228.
   Google Scholar
• Dawson D, Dominic P, Sheth A, et al. Prognostic value of cardiac biomarkers in COVID-19 infection: a meta-analysis. Sci Rep. 2021;11:4930.
   Google Scholar
• Aikawa T, Takagi H, Ishikawa K, et al. Myocardial injury characterized by elevated cardiac troponin and in-hospital mortality of COVID-19: an insight from a meta-analysis. J Med Virol. 2021;93(1):51–55.
   PubMed Web of Science ®Google Scholar
• Li X, Pan X, Li Y, et al. Cardiac injury associated with severe disease or ICU admission and death in hospitalized patients with COVID-19: a meta-analysis and systematic review. Crit Care. 2020;24(1):468.
   PubMed Web of Science ®Google Scholar
• Li J-W, Han T-W, Woodward M, et al. The impact of 2019 novel coronavirus on heart injury: a systematic review and meta-analysis. Prog Cardiovasc Dis. 2020;63(4):518–524.
   Web of Science ®Google Scholar
• Sanz-Sánchez J, Vrachatis DA, Reimers B, et al. Impact of myocardial injury on mortality in patients with COVID-19: a meta-analysis. Hellenic J Cardiol. 2020;S1109–9666(20):30177–30179.
   Google Scholar
• Zou F, Qian Z, Wang Y, et al. Cardiac injury and COVID-19: a systematic review and meta-analysis. CJC Open. 2020;2(5):386–394.
   Google Scholar
• Huang Z, Huang P, Du B, et al. Prevalence and clinical outcomes of cardiac injury in patients with COVID-19: a systematic review and meta-analysis. Nutr Metab Cardiovasc Dis. 2021;31(1):2–13.
   Web of Science ®Google Scholar
• Zeng L, Wang S, Cai J, et al. Clinical characteristics of COVID-19 with cardiac injury: a systematic review and meta-analysis. Epidemiol Infect. 2020;148:e266.
   Web of Science ®Google Scholar
• Zuin M, Rigatelli G, Zuliani G, et al. Incidence and mortality risk in coronavirus disease 2019 patients complicated by acute cardiac injury: systematic review and meta-analysis. J Cardiovasc Med. 2020;21(10):759–764.
   Google Scholar
• Hessami A, Shamshirian A, Heydari K, et al. Cardiovascular diseases burden in COVID-19: systematic review and meta-analysis. Em J Emerg Med. 2020;46:382–391.
   Web of Science ®Google Scholar
• Zhao B-C, Liu W-F, Lei S-H, et al. Prevalence and prognostic value of elevated troponins in patients hospitalised for coronavirus disease 2019: a systematic review and meta-analysis. J Intensive Care. 2020;8(1):88.
   Web of Science ®Google Scholar
• Malik P, Patel U, Patel NH, et al. Elevated cardiac troponin I as a predictor of outcomes in COVID-19 hospitalizations: a meta-analysis. Le Infez Med. 2020;28(4):500–506.
   Google Scholar